Cancer Biotherapeutics
 
MOC Mobile Banner  

Poster Information

Present a Poster at Cancer Biotherapeutics 2016

Cambridge Healthtech Institute encourages attendees to gain further exposure by presenting their work in the poster sessions. To secure a poster board and inclusion in the conference materials, your abstract must be submitted, approved and your registration paid in full by 12 February 2016.

Register online or by phone, fax or mail.  Please indicate that you would like to present a poster.  Once your registration has been fully processed, we will send an email with a unique link and instructions for submitting your abstract using our online abstract submission tool.  Please see below for more information.

Reasons you should present your research poster at this conference:

  • Your poster will be seen by our international delegation, representing leaders from top pharmaceutical, biotech, academic and government institutions
  • Receive £35 off your registration
  • Your poster abstract will be published in our conference materials 
  •   


Special poster size required:   Posters should be portrait (vertical) orientation, ISO paper size A0: (841 mm wide x 1189 mm high) or (33.11 inches wide × 46.81 inches high).  Maximum board dimensions are (1000 mm wide x 1200 mm high) or (39.37 inches wide × 47.24 inches high).  Oversize posters will not fit.

* We reserve the right to publish your poster title and abstract in various marketing materials and products.

Click here for poster instructions and guidelines

Inquiries: jring@healthtech.com

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  


Save the Date!
20-24 March 2017


Download Event Brochure


Premier Sponsors

Jackson Laboratory


View All Sponsors


View Media Partners



CONFERENCE PROGRAMS


DINNER COURSES

"Some of the most promising emergent biopharmaceuticals for cancer therapy include agents capable of selective homing to the tumor environment, as well as drugs capable of selective activation of the immune system against malignant cells."

Dario Neri, Ph.D., Swiss Federal Institute of Technology


"You have put together an amazing meeting."

Sergio A. Quezada, Ph.D., UCL Cancer Institute